| CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ... Cancer and Metastasis Reviews 29 (4), 709-722, 2010 | 896 | 2010 |
| FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication HJ Wu, M Hao, SK Yeo, JL Guan Oncogene 39 (12), 2539-2549, 2020 | 124 | 2020 |
| Role of chemokine receptor CXCR7 in bladder cancer progression M Hao, J Zheng, K Hou, J Wang, X Chen, X Lu, J Bo, C Xu, K Shen, ... Biochemical pharmacology 84 (2), 204-214, 2012 | 115 | 2012 |
| CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms G Xiao, X Wang, J Wang, L Zu, G Cheng, M Hao, X Sun, Y Xue, J Lu, ... Oncotarget 6 (16), 14165, 2015 | 99 | 2015 |
| Quantitative analysis of interactive behavior of mitochondria and lysosomes using structured illumination microscopy Q Chen, X Shao, M Hao, H Fang, R Guan, Z Tian, M Li, C Wang, L Ji, ... Biomaterials 250, 120059, 2020 | 88 | 2020 |
| Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer G Cheng, X Fan, M Hao, J Wang, X Zhou, X Sun Molecular cancer 15, 1-13, 2016 | 85 | 2016 |
| Simultaneous Zn2+ tracking in multiple organelles using super-resolution morphology-correlated organelle identification in living cells H Fang, S Geng, M Hao, Q Chen, M Liu, C Liu, Z Tian, C Wang, T Takebe, ... Nature Communications 12 (1), 109, 2021 | 75 | 2021 |
| HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk Y Wang, X Weng, L Wang, M Hao, Y Li, L Hou, Y Liang, T Wu, M Yao, ... The Journal of Clinical Investigation 128 (12), 5235-5250, 2018 | 71 | 2018 |
| HIC1 modulates prostate cancer progression by epigenetic modification J Zheng, J Wang, X Sun, M Hao, T Ding, D Xiong, X Wang, Y Zhu, G Xiao, ... Clinical cancer research 19 (6), 1400-1410, 2013 | 68 | 2013 |
| The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis L Zu, Y Xue, J Wang, Y Fu, X Wang, G Xiao, M Hao, X Sun, Y Wang, G Fu, ... Carcinogenesis 37 (3), 333-343, 2016 | 64 | 2016 |
| Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer X Chen, M Zhao, M Hao, X Sun, J Wang, Y Mao, L Zu, J Liu, Y Shen, ... Molecular Cancer Research 11 (10), 1269-1278, 2013 | 55 | 2013 |
| Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer SK Yeo, X Zhu, T Okamoto, M Hao, C Wang, P Lu, LJ Lu, JL Guan Elife 9, e58810, 2020 | 52 | 2020 |
| HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2 G Cheng, X Sun, J Wang, G Xiao, X Wang, X Fan, L Zu, M Hao, Q Qu, ... Cancer research 74 (3), 862-872, 2014 | 50 | 2014 |
| Signification of hypermethylated in cancer 1 (HIC1) as tumor suppressor gene in tumor progression J Zheng, D Xiong, X Sun, J Wang, M Hao, T Ding, G Xiao, X Wang, Y Mao, ... Cancer Microenvironment 5, 285-293, 2012 | 34 | 2012 |
| Autophagy blockade limits HER2+ breast cancer tumorigenesis by perturbing HER2 trafficking and promoting release via small extracellular vesicles M Hao, SK Yeo, K Turner, A Harold, Y Yang, X Zhang, JL Guan Developmental Cell 56 (3), 341-355. e5, 2021 | 32 | 2021 |
| Bmi-1 expression modulates non-small cell lung cancer progression D Xiong, Y Ye, Y Fu, J Wang, B Kuang, H Wang, X Wang, L Zu, G Xiao, ... Cancer biology & therapy 16 (5), 756-763, 2015 | 32 | 2015 |
| Prefused lysosomes cluster on autophagosomes regulated by VAMP8 Q Chen, M Hao, L Wang, L Li, Y Chen, X Shao, Z Tian, RA Pfuetzner, ... Cell death & disease 12 (10), 939, 2021 | 31 | 2021 |
| Light-activated mitochondrial fission through optogenetic control of mitochondria-lysosome contacts K Qiu, W Zou, H Fang, M Hao, K Mehta, Z Tian, JL Guan, K Zhang, ... Nature communications 13 (1), 4303, 2022 | 29 | 2022 |
| Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer X Sun, Q Qu, Y Lao, M Zhang, X Yin, H Zhu, Y Wang, J Yang, J Yi, M Hao BMC cancer 19, 1-11, 2019 | 29 | 2019 |
| CXCR7 in tumorigenesis and progression KL Hou, MG Hao, JJ Bo, JH Wang Chin J Cancer 29 (4), 456-459, 2010 | 28 | 2010 |
